Single-dose hepatitis A vaccination: Comparison of different dose levels in adolescents

Vaccine

Volumn 14, Issue 12, 1996, Pages 1092-1094

  Poovorawan, Yong ^a   Theamboonlers, Apiradee ^a   Safary, Assad ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Adolescents; Hepatitis A; Two dose levels

Indexed keywords

HEPATITIS A VACCINE; INACTIVATED VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEVER; HEADACHE; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

EID: 0030581354     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)00053-9     Document Type: Article

References (10)

1. 1 Hadler, S.C. Global impact of hepatitis A virus infection Changing patterns. In: Viral Hepatitis and Liver Disease (Eds Hollinger, F.B., Lemon, S.M. and Margolis, H.S.). Williams and Williams, Baltimore, 1991, pp. 14-20
2. 2 Gust, I.D. Epidemiological patterns of hepatitis A in .different parts of the world. Vaccine 1992, 10suppl. 1, 56-58
3. 3 Lemon, S.M. Type A viral hepatitis: new developments in an old disease. N. Engl. J. Med. 1985, 313, 1059-1067
4. 4 Yao, G. Clinical spectrum and natural history of viral hepatitis A in a 1988 Shanghai epidemic. In: Viral Hepatitis and Liver Disease (Eds Hollinger, F.B., Lemon, S.M. and Margolis, H.S.). Williams and Williams, Baltimore, 1991, pp. 76-78
5. 5 Poovorawan, Y., Theamboonlers, A. and Chumdermpadetsuk, S. Changing seroepidemiology of hepatitis A virus infection in Thailand Southeast Asian. J. Trop. Med. Publ. Hlth 1993, 24, 250-254
6. 6 Burke, D.S., Snitbhan, R., Johnson, D.E. and Scott, R.M. Age specific prevalence of hepatitis A virus antibody in Thailand. Am. J. Epidemiol. 1981, 113, 245-249
7. 7 Delem, A.D. Comparison of modified HAVAB and ELISA for determination of vaccine-induced anti-HAV response. Biologicals 1992, 20, 289-291
8. 8 Wiedermann, G., Ambrosch, F., Kollaritsch, H. et al. Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers. Vaccine 1990, 8, 581-584
9. 9 Innis, B.L., Snitbhan, R. and Kunasol, P. et al. Protection against hepatitis A by an inactivated vaccine. J. Am. Med. Assoc. 1994, 271, 1328-1334
10. 10 Cederna, J.B., Klinzman, D. and Stapleton, J.T. Hepatitis A virus (HAV) specific cellular immune responses following immunization with an inactivated vaccine. Presented at the 34th lntersci. Conf. Antimicrobial Agents Chemother. Orlando, 1994, abstract H10